Ogorek Anthony Joseph’s Beam Therapeutics BEAM Stock Holding History

Ogorek Anthony Joseph’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10	Closed	–	–	221
2022 Q1	$0	Buy	+10	New	+$656	﹤0.01%	245

Other funds holding BEAM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Ogorek Anthony Joseph's BEAM Position: Q2 2022 in Review

Ogorek Anthony Joseph sold out of Beam Therapeutics (BEAM) in Q2 2022, closing a stake of 10 shares.

Ogorek Anthony Joseph first reported a position in BEAM in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 205 funds tracked by Wall St. Rank hold BEAM as of Q2 2022.

Ogorek Anthony Joseph reported no remaining Beam Therapeutics position as of Q2 2022 after selling out during the quarter.
Ogorek Anthony Joseph sold 10 Beam Therapeutics shares in Q2 2022.
Ogorek Anthony Joseph first reported a position in Beam Therapeutics in Q1 2022 and held it in 1 quarter.
Ogorek Anthony Joseph's Beam Therapeutics position peaked at $0 in Q1 2022.
205 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2022.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2022, filed 21 Jul 2022.